Viking Global Equities LP

CIK 00011017858 companiesGREENWICH, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001101785

Recent Transactions

50 trades

Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-19$8.17/sh+4,957→ 22,860,013 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-18$8.21/sh+6,706→ 22,855,056 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-17$8.53/sh+6,541→ 22,848,350 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-14$7.91/sh+7,144→ 22,841,809 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-13$7.95/sh+7,367→ 22,834,665 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-12$8.30/sh+7,500→ 22,827,298 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-11$8.58/sh+7,189→ 22,819,798 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-10$8.35/sh+7,500→ 22,812,609 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-07$7.96/sh+6,649→ 22,805,109 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-06$8.00/sh+7,082→ 22,798,460 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-05$8.02/sh+6,540→ 22,791,378 total
Purchase
Myovant Sciences Ltd.
Common Shares, $0.000017727 par value per share
2019-06-04$8.25/sh+2,424,242→ 40,765,599 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-04$7.59/sh+7,500→ 22,784,838 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-03$7.71/sh+5,424→ 22,777,338 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-31$7.70/sh+5,071→ 22,771,914 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-30$7.97/sh+6,951→ 22,766,543 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-30$8.91/sh+300→ 22,766,843 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-29$7.55/sh+6,882→ 22,759,592 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-28$7.68/sh+3,807→ 22,752,710 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-24$7.70/sh+3,796→ 22,748,903 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-23$7.76/sh+4,802→ 22,745,107 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-22$8.06/sh+5,033→ 22,740,305 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-21$8.52/sh+9,995→ 22,735,272 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-20$7.98/sh+8,285
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-20$8.39/sh+1,715
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-17$7.36/sh+6,200
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-16$6.79/sh+5,408→ 22,709,077 total
Purchase
Sio Gene Therapies Inc.
Common Shares, par value $0.00001 per share
2019-03-18$1.50/sh+6,666,667→ 105,952,381 total
Purchase
Sio Gene Therapies Inc.
Common Shares, par value $0.00001 per share
2018-12-18$1.00/sh+10,000,000→ 99,285,714 total
Purchase
Urovant Sciences Ltd.
Common Shares, $0.000037453 par value per share
2018-10-01$14.00/sh+2,678,571→ 22,703,669 total
Purchase
Sio Gene Therapies Inc.
Common Shares, par value $0.00001 per share
2018-06-05$1.75/sh+14,285,714→ 89,285,714 total
Purchase
Myovant Sciences Ltd.
Common Shares, $0.000017727 par value per share
2018-04-02$20.27/sh+1,110,015→ 38,341,357 total
Purchase
Arbutus Biopharma Corp$ABUS
Series A Participating Convertible Preferred Shares
2018-01-12$100.00/sh+664,000→ 1,164,000 total
Purchase
Arbutus Biopharma Corp$ABUS
Series A Participating Convertible Preferred Shares
2017-10-16$100.00/sh+500,000→ 500,000 total
Conversion
FIRST DATA CORP
Class B Common Stock
2016-04-13−317,519→ 0 total
Conversion
FIRST DATA CORP
Class A Common Stock
2016-04-13+5,874,105→ 5,874,105 total
Conversion
FIRST DATA CORP
Class B Common Stock
2016-04-13−10,144,738→ 0 total
Conversion
FIRST DATA CORP
Class B Common Stock
2016-04-13−5,413,702→ 0 total
Conversion
FIRST DATA CORP
Class B Common Stock
2016-04-13−21,750,064→ 0 total
Conversion
FIRST DATA CORP
Class A Common Stock
2016-04-13+5,413,702→ 5,413,702 total
Conversion
FIRST DATA CORP
Class A Common Stock
2016-04-13+21,750,064→ 21,750,064 total
Conversion
FIRST DATA CORP
Class A Common Stock
2016-04-13+317,519→ 317,519 total
Conversion
FIRST DATA CORP
Class A Common Stock
2016-04-13+10,144,738→ 10,144,738 total
Conversion
FIRST DATA CORP
Class B Common Stock
2016-04-13−5,874,105→ 0 total
Conversion
Editas Medicine, Inc.$EDIT
Series B Preferred Stock
2016-02-08−4,444,444→ 0 total
Conversion
Editas Medicine, Inc.$EDIT
Series B Preferred Stock
2016-02-08−4,444,444→ 0 total
Conversion
Editas Medicine, Inc.$EDIT
Series B Preferred Stock
2016-02-08−4,444,444→ 0 total
Conversion
Editas Medicine, Inc.$EDIT
Series B Preferred Stock
2016-02-08−4,444,444→ 0 total
Purchase
Editas Medicine, Inc.$EDIT
Common Stock
2015-02-08+481,567→ 481,567 total
Purchase
Editas Medicine, Inc.$EDIT
Common Stock
2015-02-08+261,447→ 261,447 total

Companies

Recent Filings

Address

55 RAILROAD AVENUE

GREENWICH, CT, 06830

View on SEC.gov